Phase II trial of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus

被引：0
|
作者：
Qi, Y. [1 ]
Wei, S. [1 ]
Shao, L. [1 ]
机构：
[1] Tumor Hosp Gansu Prov, Radiat Oncol, Lanzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1545P
引用
收藏
页码：S867 / S867
页数：1
相关论文
共 50 条
  • [1] Efficacy of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus: A randomized, open-label, phase II trial
    Qi, Y.
    Shao, L.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1551 - S1551
  • [2] A PHASE II TRIAL OF NIMOTUZUMAB IN COMBINATION WITH CHEMORADIOTHERAPY IN LOCALLY ADVANCED LUNG SQUAMOUS CELL CARCINOMA
    Zhou, Lin
    Liu, Jia
    Liu, Rong-Mei
    Gong, You-Ling
    Zhang, Xin-Xing
    Wang, Jin
    Xu, Yong
    Huang, Mei-Juan
    Bai, Seng
    Duan, Ping
    Lu, You
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1572 - S1573
  • [3] Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
    Li, Hui
    Gu, Dayong
    Du, Mingyu
    Zhou, Guoren
    Zhang, Zhi
    Ye, Jinjun
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Nimotuzumab in combination with preoperative concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A prospective trial
    Wu, Xiaoyuan
    Chen, Yongshun
    Yang, Yuanyuan
    Hao, Daxuan
    Li, Xue
    He, Chunyu
    Liu, Jinsong
    Wang, Jianhua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] The Efficacy and Safety of Continuous Intravenous Endostar Treatment Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: A Randomized Controlled Trial
    Shu, Hang
    Dong, Yaqin
    Xu, Zhonghua
    Luo, Weiwei
    Xu, Lei
    Zhu, Haochen
    Cheng, Linghui
    Lv, Yin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [7] Phase II study of concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced squamous cell carcinoma of the oral cavity
    Adilbaev, G. -B.
    Kidirbaeva, G.
    Savhatova, A. -D.
    Turesheva, A. -O.
    Adilbay, D. -G.
    [J]. ORAL ONCOLOGY, 2011, 47 : S28 - S28
  • [8] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [9] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    [J]. British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [10] A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus
    Zhao, Kuai-le
    Hu, Xi-chun
    Wu, Xiang-hua
    Fu, Xiao-long
    Fan, Min
    Jiang, Guo-Liang
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1585 - 1590
12345